NAFDAC Mandates Recall of Dangerous Cough Syrup, Advises Nigerians

Cough Syrup Recall: Several African Countries Take Action
Punch NG

NAFDAC Mandates Recall of Dangerous Cough Syrup, Advises Nigerians

The National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a recall of Benylin Paediatrics Syrup manufactured by Johnson & Johnson due to recent findings of toxicity in laboratory tests. The analysis revealed an unacceptably high level of Diethylene glycol, a substance known to cause acute oral toxicity in laboratory animals.

A product recall is a standard procedure in response to safety concerns, design defects, or labeling errors. NAFDAC has directed the marketing authorization holder, Johnson and Johnson company West Africa, to initiate the recall process for the affected batch. The recall notice will also be uploaded to the WHO Global Surveillance and Monitoring System.

Benylin Paediatric syrup is commonly used to relieve cough and congestive symptoms in children aged two to 12 years. However, the presence of Diethylene glycol in the product poses serious health risks, including abdominal pain, vomiting, diarrhea, altered mental state, and acute kidney injury, which can be fatal if ingested.

The affected product, with batch number 329304, was manufactured in May 2021 and is set to expire in April 2024. NAFDAC advises importers, distributors, retailers, and consumers to exercise caution and vigilance within the supply chain to prevent the importation, distribution, sale, and use of contaminated products.

NAFDAC emphasizes the importance of obtaining medical products from authorized/licensed suppliers and checking the authenticity and physical condition of the products. Consumers who possess the recalled product are urged to discontinue its use immediately and submit it to the nearest NAFDAC office. Additionally, any adverse reactions or events should be reported to healthcare professionals and NAFDAC for further investigation.

Healthcare professionals and consumers are encouraged to report any suspicion of substandard or falsified medicines to NAFDAC, either through their website, email, or designated reporting platforms. NAFDAC remains committed to regulating and controlling the quality of food, drugs, cosmetics, medical devices, and other regulated products to ensure public safety and health.


Related Posts